Venclyxto (venetoclax) supply for hospitals & distributors
BCL-2 inhibitor · AbbVie
Venclyxto (venetoclax; marketed as Venclexta in the US) is AbbVie's oral BCL-2 inhibitor for chronic lymphocytic leukaemia and acute myeloid leukaemia. Treatment starts with a weekly dose ramp-up, which is why it comes in three tablet strengths and a starting pack.
Prescription-only medicine. No prices are published. Supply is to hospitals, distributors, pharmacies and physicians against a valid prescription or purchase order. This page is product information, not medical advice.
Product facts
Strengths and presentation
- 10 mg, 50 mg and 100 mg film-coated tablets
- Starting (titration) pack for the 5-week CLL ramp-up
Approved indications (EMA / FDA label summary)
- Chronic lymphocytic leukaemia — with obinutuzumab, with rituximab, with ibrutinib, or as monotherapy (label-dependent)
- Newly diagnosed acute myeloid leukaemia in patients ineligible for intensive chemotherapy, with a hypomethylating agent (label-dependent)
Short label summary only. Approved indications differ by country and line of therapy; the national label in the destination country governs.
Storage and cold chain
- Room-temperature product — store as stated on the carton, in the original pack
- No cold chain required; shipped in tamper-evident, temperature-protected packaging
How we supply
- Original manufacturer packs only — sourced from licensed wholesalers in Türkiye and Europe, never repackaged or relabelled.
- Batch number and expiry confirmed in writing before dispatch; every pack is traceable to its batch.
- Documents with every consignment: commercial invoice, batch / CoA information from the source, and packing list.
- Tamper-evident, temperature-protected shipping; no cold chain is required for this product.
- Named-patient and special-import support: we prepare the paperwork your hospital or importer needs for the local regulator.
Procurement notes
The first five weeks of CLL treatment use the starting pack (20 → 50 → 100 → 200 → 400 mg), after which supply switches to 100 mg tablets. Tell us which phase the patient is in so the right packs are sourced; AML regimens use a different ramp-up.
Who we supply
- Hospital pharmacy and procurement departments
- Licensed pharmaceutical distributors and importers
- Oncology and haematology centres
- Treating physicians arranging named-patient supply
Markets served
United Arab Emirates, Saudi Arabia, Qatar, Kuwait, Oman, Bahrain and Iraq. Import into each country follows that country's regulator (for example MOHAP / DoH / DHA, SFDA, MoPH, Kuwait MOH, Oman MOH, NHRA) — we work with the receiving institution's import route.
Frequently asked questions
Can you supply the Venclyxto starting pack?
Yes, subject to availability. The starting pack and the 100 mg maintenance tablets are quoted separately because they are used in different weeks of treatment.
Is Venclyxto the same product as Venclexta?
Venclyxto (EU and most markets) and Venclexta (US) are the same active substance, venetoclax, from AbbVie under different regional brand names.
Is the Venclyxto you supply an original manufacturer pack?
Yes. We supply Venclyxto only in the original AbbVie pack, sourced from licensed wholesalers in Türkiye and Europe, never repackaged or relabelled.
Which documents come with a consignment?
Commercial invoice, batch / CoA information from the source and a packing list, with batch number and expiry for every pack. Additional documents requested by your importer can be prepared.
Do you supply the UAE, Saudi Arabia, Qatar, Kuwait, Oman, Bahrain and Iraq?
Yes — to hospitals, distributors and licensed centres in these countries, through the import or named-patient route accepted by the destination country's regulator.
How do I get a quote for Venclyxto?
Send a supply inquiry on WhatsApp with strength, quantity, country and institution. We reply with a written quote, availability and expiry; we do not publish prices on the site.
Send a supply inquiry
Tell us the product, strength, quantity, destination country and the receiving institution. We reply with availability, batch/expiry and the documentation set — and a written quote. We do not sell to the public.
Send a supply inquiryOther medicines we supply to the Gulf
- Keytruda (pembrolizumab)
- Opdivo (nivolumab)
- Enhertu (trastuzumab deruxtecan)
- Tagrisso (osimertinib)
- Darzalex (daratumumab)
- Imfinzi (durvalumab)
- Tecentriq (atezolizumab)
- Perjeta (pertuzumab)
- Kadcyla (trastuzumab emtansine)
- Lynparza (olaparib)
- Revlimid (lenalidomide)
- Imbruvica (ibrutinib)
- Xtandi (enzalutamide)
- Adcetris (brentuximab vedotin)
Sources
Reviewed by Pharmacy Remedy Pharmacovigilance & Compliance Desk · Last updated: 2026-11-04